ERBB2 and breast cancer: As the preliminary experiments conducted revealed significant drug effect in the case of combined use of TZ and BMS-202 on HER2+ BC cells, we proceeded to collect time-series data to estimate the parameters for a mathematical model of cancer growth and drug-induced growth inhibition.